MAM
McLean Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-263
| Closed | -$266K | – | 164 |
|
|
2024
Q3 | $266K | Hold |
263
| – | – | 0.08% | 130 |
|
|
2024
Q2 | $282K | Sell |
263
-99
| -27% | -$106K | 0.09% | 117 |
|
|
2024
Q1 | $342K | Buy |
362
+1
| +0.3% | +$944 | 0.12% | 97 |
|
|
2023
Q4 | $330K | Sell |
361
-3
| -0.8% | -$2.74K | 0.12% | 90 |
|
|
2023
Q3 | $304K | Hold |
364
| – | – | 0.12% | 93 |
|
|
2023
Q2 | $262K | Sell |
364
-1
| -0.3% | -$719 | 0.1% | 106 |
|
|
2023
Q1 | $300K | Sell |
365
-4
| -1% | -$3.29K | 0.12% | 93 |
|
|
2022
Q4 | $266K | Buy |
369
+4
| +1% | +$2.89K | 0.09% | 104 |
|
|
2022
Q3 | $264K | Buy |
365
+9
| +3% | +$6.51K | 0.1% | 95 |
|
|
2022
Q2 | $212K | Sell |
356
-3
| -0.8% | -$1.79K | 0.08% | 119 |
|
|
2022
Q1 | $251K | Buy |
359
+9
| +3% | +$6.29K | 0.19% | 102 |
|
|
2021
Q4 | $221K | Sell |
350
-56
| -14% | -$35.4K | 0.09% | 123 |
|
|
2021
Q3 | $240K | Hold |
406
| – | – | 0.09% | 115 |
|
|
2021
Q2 | $237K | Buy |
+406
| New | +$237K | 0.11% | 99 |
|
|
2021
Q1 | – | Sell |
-414
| Closed | -$200K | – | 106 |
|
|
2020
Q4 | $200K | Buy |
+414
| New | +$200K | 0.18% | 94 |
|